IMAX Corporation filings document the formal records behind its entertainment-technology business, NYSE-listed common shares and reported operating results. Recent Form 8-K disclosures cover quarterly and annual financial results, global box office metrics, system installations and signings, material agreements and financing activity, including convertible senior notes.
Proxy materials describe board matters, executive compensation, equity awards and shareholder voting items. Other current reports address leadership-continuity and governance disclosures, while filings also identify the company as a Canadian corporation with operations reported through Content Solutions and Technology Products and Services.
IMAX CORP (IMAX) reported an insider transaction by Pablo Calamera, CTO & EVP. On 2026-08-20, he completed an open-market sale of 15,000 common shares at a price of $52.4116 per share. Following this sale, he directly held 43,012 common shares, and his aggregate remaining outstanding restricted share units totaled 20,840.
IMAX Corporation (IMAX) is the issuer of common stock that Richard Gelfond, identified as an officer, plans to sell under Rule 144. A broker, Goldman Sachs & Co. LLC, has been designated to sell 100,000 shares of IMAX common stock, with an indicated aggregate value of $5,274,000. The filing also lists prior sales by Gelfond during the past three months and shows IMAX common shares outstanding of 54,842,114 as of August 20, 2026.
IMAX CORP (IMAX) reported insider transactions by Chief Executive Officer Richard L. Gelfond involving option exercises and share sales executed under a Rule 10b5-1 trading plan dated May 19, 2026. On August 18 and 19, 2026, he converted stock options into a total of 356,757 common shares at an exercise price of $31.90 per share and sold the converted shares in open-market transactions. He also sold an additional 100,000 common shares on August 20, 2026.
Following these transactions, Mr. Gelfond’s aggregate remaining holdings are disclosed as 975,654 stock options, 231,562 restricted share units, and 665,002 common shares.
IMAX CORP (IMAX) has a notice of proposed sale filed under Rule 144 by Pablo M. Calamera covering common shares. The filing lists 15,000 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $786,174.00 and listing on the NYSE. The securities relate to restricted stock vesting under a registered plan, acquired from the issuer for services rendered, with a stated sale date of 03/07/2025.
IMAX CORP (IMAX) is the issuer of common shares that a person named Richard Gelfond plans to sell under Rule 144. A broker, Goldman Sachs & Co. LLC, is listed to sell 205,504 shares of common stock, with an aggregate market value of $11,037,619.84, on or after August 19, 2026. The shares were originally acquired as compensation via stock options and will be disposed of through a cashless exercise / same-day sale. IMAX common stock is listed on the NYSE, and there were 54,842,114 shares outstanding at the time referenced for this notice. In the prior three months, Gelfond reported sales of 151,253 shares for total consideration of $7,714,644.14. The filing states these transactions are made under a selling plan dated May 19, 2026 intended to comply with Rule 10b5-1(c).
IMAX Corporation (IMAX) received a notice that Richard Gelfond plans to sell common shares under SEC Rule 144. Up to 151,253 shares may be sold through Goldman Sachs & Co. LLC on the NYSE, in connection with a Rule 10b5-1(c) selling plan dated 05/19/2026. The shares were acquired as compensation via stock options and are to be sold through a cashless exercise and same-day sale mechanism.
Nomura Asset Management International Inc. and Nomura Investment Management Business Trust report beneficial ownership of IMAX CORP common shares on an amended Schedule 13G. They hold 2,936,661 IMAX common shares with shared voting and dispositive power and no sole power.
This position represents 5.4% of IMAX’s common shares, based on 54,842,114 shares outstanding as of June 30, 2026, as reported in IMAX’s Form 10-Q for that quarter. The filing also notes that it excludes securities, if any, beneficially owned by Nomura Holdings Inc. and certain of its subsidiaries pursuant to a prior SEC release.
Orbis Investment Management Limited and Allan Gray Australia Pty Ltd report beneficial ownership of IMAX Corp common stock. Together they report owning 5,149,555 shares, representing 9.4% of the outstanding common stock.
Orbis holds sole voting and dispositive power over 5,129,735 shares, while Allan Gray Australia holds sole voting and dispositive power over 19,820 shares. Each entity is a non-U.S. institution equivalent to an investment adviser and disclaims beneficial ownership of shares reported by the other, and they state that they are not representing themselves as a Section 13(d)(3) group.
IMAX Corp senior vice president, controller and principal accounting officer Jose Aleksandr Zlatar reported an open-market sale of 500 common shares on August 6, 2026 at $49.90 per share. Following these transactions, he directly holds 583 common shares and 6,695 restricted share units.